Skip to content

Menu

Seyfarth Shaw LLP logo
HomeAboutAuthorsSubscribe
Search
Close

Beneficially Yours

Home » Sad Day for Coupon-Clippers

Sad Day for Coupon-Clippers

By Ben Conley on February 11, 2020
Posted in Health & Welfare Plans

Seyfarth Synopsis: Recently, the Trump Administration issued its proposed Notice of Benefit & Payment Parameter for 2021 regulations. While these regulations primarily impact insurance carriers participating in the Health Insurance Marketplaces/Exchanges (outlining services that must be covered and rules surrounding that coverage), employer plan sponsors had been anticipating these rules to see how the Administration would address manufacturers’ coupons and their applicability toward cost-sharing limits (i.e., plan deductibles and out-of-pocket maximums).

For background, plan sponsors had been increasingly grappling with participants veering toward extremely high-cost drugs, despite the sponsors’ plan designs imposing higher cost-sharing for those drugs, because manufacturers were offering participants coupons to offset those participants’ cost-sharing obligations. In those cases, the plan was on the hook for its share of the high cost of the drug, but the participant paid no more than a typical prescription. In response, many employers had implemented programs excluding the value of manufacturers’ coupons from the participants’ cost-sharing obligations under the plan. The rationale here was that if the participant didn’t actually pay the cost (because the manufacturer did), there should be no crediting under the plan’s accumulators.

A prior iteration of the Administration’s rules had suggested that if a participant used a manufacturer’s coupon to pay for a portion of his or her cost-sharing obligation, the value of the coupon would have been required to count toward the plan’s out-of-pocket maximum, except where a generic drug was available. This potentially impacted plan sponsors’ ability to effectively mold a value-based insurance design incentivizing participants to use a lesser-cost drug where available. Further, it was in direct conflict with IRS rules for high deductible health plans (“HDHPs”), which generally prohibited plans from counting the value of coupons toward a participant’s cost-sharing obligation in order to preserve health savings account (“HSA”) eligibility.

In response to feedback, the Administration temporarily halted the application of the prior rules in order to solicit additional comments. Based on those comments, the new rules provide plan sponsors the ability to choose whether to count or exclude the value of coupons in determining whether a participant has satisfied his or her cost-sharing obligations. We suspect that most plan sponsors (and especially those with an HDHP that is intended to be HSA-compatible) will move to exclude the value of coupons in response to this rule (if finalized in substantially the same form).

The Administration invites comments on this rule, which are due no later than March 2, 2020.

Tags: HDHP, health savings account, high deductible health plan, HSA
Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Ben Conley Ben Conley
Read more about Ben Conley
Related Posts
towfiqu-barbhuiya-gGIxh0iBx2I-unsplash
States Seeking Remedies for the Rising Costs of Prescription Drugs
June 5, 2025
jeremy-thomas-FO7bKvgETgQ-unsplash (1)
Parity in Peril? Plan Sponsors Breathe Easier As Trump Administration Hits Pause on Enforcement of Mental Health Parity Final Rule
May 16, 2025
towfiqu-barbhuiya-w8p9cQDLX7I-unsplash (1)
Cutting Out the Middle Man
April 24, 2025
Reproductive Health Law Update

Stay Connected

RSS Twitter LinkedIn Facebook

Recent Updates

  • Supreme Court Upholds Tennessee Transgender Care Ban
  • Seyfarth’s Beneficially Yours Blog Ranked #1 in FeedSpot’s Top 35 ERISA Blogs
  • States Seeking Remedies for the Rising Costs of Prescription Drugs
  • Parity in Peril? Plan Sponsors Breathe Easier As Trump Administration Hits Pause on Enforcement of Mental Health Parity Final Rule
  • Seyfarth Sponsors IEL Executive Compensation & Benefits Summit

Topics

Archives

Links & Resources

  • ADA Title III Blog
  • Big Immigration Law Blog
  • California Peculiarities Employment Law Blog
  • Carpe Datum Law Blog
  • Consumer Class Defense Blog
  • EEOC Year-End Countdown
  • Employment Law Lookout
  • Future Enterprise
  • Management Writes: Practical Labor Law Updates
  • The Blunt Truth®
  • The Construction Seyt
  • The Global Privacy Watch Blog
  • Trading Secrets Law
  • Wage & Hour Litigation Blog
  • Workplace Class Action Blog
  • Workplace Law & Strategy
  • Workplace Safety and Environmental Law Alert Blog
Seyfarth Shaw LLP logo
RSS Twitter LinkedIn Facebook
Privacy PolicyAttorney AdvertisingSubscribe

About Our ERISA Litigation and Employee Benefits Teams

Seyfarth’s Beneficially Yours Blog is a resource for companies looking for news behind the headlines on all things employee benefits — including benefits litigation — affecting their business. This blog covers the latest hot topics related to ERISA and employee benefits, ranging from litigation trends to compliance issues. Our ERISA litigation team, together with our employee benefits and executive compensation team, draw on their first-hand experience in handling ERISA and employee benefits matters to provide you with insight about the most cutting-edge issues in the field.

Copyright © 2025, Seyfarth Shaw LLP. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo